B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Knabbe, C., Berthold, H
Some researchers have suggested that these promising results warrant further research to study the compounds potential benefits for metabolic conditions like type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD) [5]
[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Gojkovic S., Krezic I., Vranes H., Zizek H., Drmic D., Batelja Vuletic L., Milavic M., Sikiric S., Stilinovic I., Simeon P., et al
BPC-157 TB-500 Side Effects & Safety BPC-157 Generally very well tolerated in research models Minimal reported side effects at standard doses No significant hormonal impact Theoretical concern: may promote angiogenesis in existing tumors (same as any pro-angiogenic compound) TB-500 Well tolerated
The increase of endothelial tube formation induced by BPC 157 was also inhibited by dynasore
Ethics declarations Conflict of interest The authors report no conflict of interest
